Canary Foundation and Stanford University Commit $20 Million for World-Class Research Center for Cancer Early Detection
Center will be the first in the world to integrate research on both in vivo and in vitro diagnostics to deliver blood and complementary imaging tests for solid tumor cancers
The new center will include a first-of-its-kind facility that combines in vitro and in vivo strategies to enhance future cancer detection and patient management. The center will include cancer proteomic research for early blood/body fluid markers (in vitro diagnostics) and molecular imaging (in vivo) to verify the presence and location of tumors. Currently, there is a lack of clinical tools that reliably detect signs of early tumors. If these tools were made available, the hope is that physicians would have a much better chance of treating and even curing cancer.
Related Content
Comments
